在FDA的紫色书中列出的生物制药产品的全面分析

相关实验视频

Updated: Jun 28, 2025

09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.4K

Fuduan Chen¹, Hao Zhong¹, Ging Chan¹

¹State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, 999078, China.

AAPS PharmSciTech

|April 18, 2024

概括

生物制药产品占据销量第一位,但在稳定性和配方方面面临挑战. 创新的输送策略对于未来的生物药物开发和满足医疗保健需求至关重要.

科学领域:

制药科学制药科学
生物技术是生物技术.
药物开发药物开发

背景情况:

生物制药是制药市场的重要和不断增长的部门,2023年销量前十大药物中有八种是生物制药.
尽管生物技术的进步和简化审批流程,生物药物分子稳定性和配方设计的挑战仍然存在.

研究的目的:

对FDA的紫色书数据库进行全面分析,以了解市场趋势和生物制品的分销.
研究生物配方的策略,包括注射途径,剂型,包装和辅助剂.
确定创新性交付策略在应对医疗保健挑战和满足治疗需求方面的作用.

主要方法:

美国食品和药物管理局 (FDA) 紫色图书数据库的全面分析.
检查生物药物的市场趋势和分销模式.
分析生物配方策略,包括管理,剂量,包装和辅助剂.

主要成果:

生物制品尽管仅占药品市场的10%,但在销售方面处于领先地位,这表明其对市场的影响很大.
确定的主要挑战包括分子不稳定性和复杂的配方设计,阻碍了更广泛的应用.
分析了配方中的重要策略,例如注射途径,剂型,包装和辅助剂.

结论:

生物制药行业显示出巨大的市场潜力和增长,由创新的生物药物驱动.
克服稳定性和配方方面的挑战对于推进生物疗法至关重要.
整合创新的传递系统与生物药物对于解决未来的医疗需求和改善患者结果至关重要.

关键词:

生物学的生物学.生物制药领域的景观剂量形式剂量形式辅助剂是一种辅助剂.紫色的书,就是紫色的书.

相关概念视频

01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.0K

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...

2.0K

01:16

Bioequivalence: Overview

1.0K

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

1.0K

01:02

Prescription, Nonprescription and Orphan Drugs

724

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

724

00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...

01:12

Analysis of Population Pharmacokinetic Data

254

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

254